A non-invasive eye exam, similar to those given in eye doctors’ offices, might someday help predict a person’s risk of…
Articles by Patricia Inacio, PhD
New genetic variants that may affect a person’s risk for developing Alzheimer’s disease have now been identified as part…
Approved medication memantine could be used as a preventive treatment to help stop or delay Alzheimer’s disease progression in…
The buildup of beta-amyloid plaques in the brain is not sufficient on its own to cause the death of neurons…
Drinking alcohol, especially in excess, may hinder the brain’s natural ability to clear itself of amyloid beta protein plaques, the underlying…
ProMIS Neurosciences announced plans to initiate the development of its lead antibody candidate, PMN310, as a potential treatment for Alzheimer’s disease. The investigational…
Medications for type 2 diabetes may help treat symptoms of Alzheimer’s, as these two conditions share common disease mechanisms, according…
A Phase 1 trial to evaluate the safety and effectiveness of Longeveron’s allogeneic mesenchymal stem cells (LMSCs) in patients…
Alkahest‘s Phase 2 clinical trial testing GRF6019 — an experimental blood-derived protein — in patients with mild to moderate Alzheimer’s…
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is searching for participants to enroll in one of the largest and longest…